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                               INTRODUCTION 
  Malaria is a protozoan disease caused by the protozoan ,plasmodium. Five species of the 
genus plasmodium causes nearly all malarial infections in humans - Plasmodium 
falciparum,Plasmodium vivax,Plasmodium ovale,Plasmodium malariae and Plasmodium 
knowlesi. Malaria is transmitted by the anopheles mosquitoes. 
Life cycle 
When thefemale mosquito bites a human being,sporozoites are introduced into the 
circulation. Sporozoites then reaches the liver and undergo pre erythrocytic schizogony. 
Within  the liver cells sporozites get divided and give rise to merozoites. The swollen 
hepatocytes then burst and release the  merozoites. Each  merozoite then invades 
erythrocytes and undergoes erythrocytic  schizogony. Merozoites then develop into 
tropozoites and later into schizonts. The schizonts divided to form merozoites. Then the 
RBC bursts to release the merozoites which inturn invade new RBCs. Some of the 
merozoites develop into gametocytes that can transmit the disease. Some of the 
sporozoites in  theb hepatocytes can develop into dormant form called hypnozoites in 
P.vivax and P.ovale infection. When another mosquito feeds on the malaria patient,the 
female and male gamatocytes reaches the gut of the mosquito where they combine 
together to form the zygote. Zygote matures into ookinete and penetrates into the gut wall 
where it encysts and form oocyst. Later oocyst  divides to form sporozoites. These 
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sporozoites are stored in salivary gland of the mosquito and injected into another person 
during the mosquito bite. 
Clinical  features 
Malarial fever begins with non specific complaints of headache,fatigue,abdominal 
discomfort, and myalgia. These non specific  symptoms are followed by high grade 
intermittent fever,associated with chills and rigor. According to the periodicity  fever in 
malaria are classified into tertian fever(p.vivax and p.ovale),quartian fever (p.falciparum) 
etc. Anemia,jaundice and hepatospleenomegaly are other features seen in malarial 
fever.If a patients with malaria developsunarousable coma/cerebral 
malaria,acidosis,severe anemia,renal failure,ARDS,hypoglycemia,shock,DIC, 
hemoglobinuria,convulsions etc then it is considered as complicated malaria. Further 
metabolic abnormalities like hypoglycemia,hypocalcemia,hyponatremia etc are also  
noted in malarial fever. Exact causes of hypocalcemia in malaria is not known. Renal 
failure,hypomagnesemia and hypoparathyroidism are some of the possible causes of 
hypocalcemia in malaria. 
Hypocalcemia  
Normal  serum calcium level is 8.5-10.2 mg% . Of this 50 % remain bound to serum 
proteins and 50% remain free in the circulation. Serum calcium level < 8.5 mg% is taken 
as hypocalcemia. Causes of hypocalcemia are classified according to whether serum PTH 
level are low(hypoparathyroidism) or high(secondary hyperparathyroidism). Patients 
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remain asymptomatic in mild and chronic hypocalccemia or they may present with life 
threatening complications. Moderate hypocalcemia presents with 
parasthesia,especiallyover fingers and circum oral areas. Carpopedal spasm. Chevstok’s 
sign and trosseau’s signs can be elicited on clinical examination of these patients. Severe   
hypocalcemia presents with 
seizures,carpopedalspasm,bronchospasm,laryngospasm,prolongation of QT interval and 
arrhythmias. 
Carpopedal spasm has been noted in many patients presenting with malarial fever. Most 
of the patients are ,later found to have hypocalcemia. There are only few studies on the 
prevalence and clinical implication of hypocalcemia in malaria. Hypocalcemia associated 
with malaria can cause many clinical manifestations ,including life threatening conditions 
such as arrhythmias,convulsions etc. Less is known about the prevalence of 
hypocalcemia in malaria and and its effect on clinical outcome. So, i conducted a cross 
sectional study among patients presenting with malarial fever in Stanley medical  college. 
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                         REVIEW OF LITRATURE 
Epidemiology  
   Malaria is a tropical disease. Amongst the different species  P. falciparum predominates 
in Africa,new guinea and Haiti while P.vivax predominates in central America. Both 
species are equally seen in regions like South America,Indian subcontinent,Eastern asia 
and Oceania. P .malaria is endemic to sub Saharan region whereas  P. ovale is rarely 
found outside Africa. P.knowlesi is reported in the islands of Borneo and Southeast asia. 
Endemic  areas have been  classified as hypoendemic(<10% of chidren with palpable 
spllen),mesoendemic(11-50%),hyperendemic(51-75%) and 
holoendemic(>75%)according to parasites rate or palpable spleen rates in chidren of age 
2-9 years. In holo and hyper endemic areas,people get more than one infected mosquito 
bites per day and are infected repeatedly throughout life. Prevalence and incidence of 
malarial fever is more in children in endemic areas.  
     Two types of disease transmission have been noted- stable transmission and unstable 
transmission. Constant, frequent and year round transmission is called stable transmission 
whereas low,focal transmission is termed as unstable transmission. Stable transmission is 
seen in holo endemic and hyper endemic areas whereas unstable transmission is found in 
hypo endemic areas. Transmission rate of malaria is dependent on density of 
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vectors,number of human bites per day and life span/longevity of mosquitoes. Malaria is 
less common in high altitudes and areas with cold climate. 
Life cycle of malarial parasite 
figure 11 
Pathophysiology  
Severe malaria occurs when there is  adhesion and sequestration of parasitized red blood 
cells(PRBC) in the vasculature,release of bio active molecules by the parasites and host 
inflammatory responses. The parasitized RBC(PRBC)  becomes less deformable so that it 
can’t  pass through the microcirculation. This leads to sequestration of PRBC within the 
microcirculations causing tissue ischemia. Surface of the PRBC become rough and leads 
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to increased adherence of PRBC to vascular endothelium. Adherence of PRBC with 
another PRBC (agglutination) and PRBC with non PRBC (rossetting) also take place. 
Reduction in cell deformability is observed not only in PRBC, but also in NPRBC. All 
these factorslead to blockade of microcirculation in various tissues, thus causing tissue 
ischemia. 
       Host immune responses also contribute to the pathogenesis of complicated malaria. 
Concentration of various proinflammatory cytokines are found to be elevated. TNF-alpha 
upregulates endothelial cytoadherence receptors andcan cause hypoglycemia and 
dyserythropoeisis. Cytoadherence and sequestration of PRBCs in microcirculation is seen 
in P.falciparum infection. 
Clinical features 
Malaria is one of the most common causes of acute febrile illness in tropical countries. 
Initial symptoms of malaria are mostly non specific includingheadache,fatigue,abdominal 
discomfort, myalgia and arthralgia, which is followed by fever. High grade fever with 
chills and rigor is seen. The fever spikes occur at regular intervels. The spike of fever 
corresponds to the release of merozoites from PRBCs. Fever appears every second day in 
P.vivax and P.ovale malarial infection and is called tertian fever. Quartian fever(fever 
spikes comes every third day) is seen in P.falciparum and P.malaria infection. In 
P.knowlesi infection ,fever spike is seen every 24 hours. 
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     Mild jaundice and hepato splenomegaly  are seen in malarial infection. Uncomplicated 
malarial infection resolves over 1-3 weeks. 
 
Manifestations of Severe Falciparum Malaria - Signs Manifestations 
Major 
 Unarguable coma/cerebral malaria 
Coma persisting for>30 min after generalized convulsion .Failure to localize or respond 
appropriately to noxious stimuli 
 Acidemia/acidosis 
Arterial pH of <7.25 or plasma bicarbonate level of <15 mmol/L; venous lactate level of 
>5 mmol/L; Patients develop labored deep breathing, often termed “respiratory distress” 
 Severe normochromic,normocytic anemia 
Hemoglobin level of <50 g/L (<5 g/dl) or hematocrit of <15% with parasitemia level of 
>100,000/μL 
 Renal failure 
 Urine output of<400 ml in 24 hours in adults or <12 ml/kg in children; no improvement 
with rehydration; serumcreatinine level of >265 μmol/L (>3 mg/dl) 
 Pulmonary edema/adult respiratory distress syndrome 
Overhydration aggravates noncardiogenic pulmonary edema 
 Hypoglycemia 
 Plasma glucose level of <2.2 mmol/L (<40 mg/dl) 
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 Hypotension/shock  
Systolic blood pressure of <50 mmHg in children 1–5 years or <80 mmHg in adults; 
core/skin temperature difference of >10°C; capillary refill >2 s 
 Bleeding/disseminatedintravascular coagulation 
Patients will have significant bleeding and hemorrhage from the gums, nose, and 
gastrointestinal tract and/or evidence ofdisseminated intravascular coagulation 
 Convulsions  
More than two generalized seizures in 24 h. sometimes subtle (e.g., toniccloniceye 
movements without limb or face movement) is noted 
 Hemoglobinuria 
Macroscopic black, brown, or red urine; not associated with effects of oxidant drugs and 
red blood cell enzymedefects (such as G6PD deficiency).It is called black water fever. 
Other 
 Impaired consciousness/arousable 
Unable to sit or stand without support 
 Extreme weakness 
 Prostration; inability to sit without help 
 Hyperparasitemia  
Parasitemia level of >5% in nonimmune patients (>20% in any patient) 
 Jaundice 
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 Serum bilirubin level of >50 mmol/L (>3 mg/dl) if combined with other evidence of 
vital-organ dysfunction 
 
 
Features Indicating Poor Prognosis in Severe Falciparum Malaria 
Clinical 
Marked agitation 
Hyperventilation (respiratory distress) 
Hypothermia (<36.5°C) 
Bleeding 
Deep coma 
Repeated convulsions 
Anuria 
Shock 
 
Laboratory 
Biochemistry 
Hypoglycemia (<2.2 mmol/L) 
Hyperlactatemia (>5 mmol/L) 
Acidosis (arterial pH <7.3, serum HCO3 <15 mmol/L) 
Elevated serum creatinine (>265 μmol/L) 
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Elevated total bilirubin (>50 μmol/L) 
Elevated liver enzymes (AST/ALT 3 times upper limit of normal) 
Elevated muscle enzymes (CPK ↑, myoglobin ↑) 
Elevated urea (>600 μmol/L) 
 
Hematology 
Leukocytosis (>12,000/μL) 
Severe anemia (PCV <15%) 
Coagulopathy 
     Decreased platelet count (<50,000/μL) 
     Prolonged prothrombin time (>3 s) 
     Prolonged partial thromboplastin time 
     Decreased fibrinogen (<200 mg/dl) 
 
Parasitology 
Hyperparasitemia 
    Increased mortality at >100,000/μL 
    High mortality at >500,000/μL 
>20% of parasites identified as pigment-containing 
trophozoites and schizonts 
>5% of neutrophils with visible pigment 
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Hypocalcemia in malaria 
Many previous studies revealed the disturbance of calcium homeostasis in malaria. Many 
possible mechanisms are suggested to explain the relation between malaria and 
hypocalcaemia. This effect is found most severe in Falciparum malaria .The nature of the 
mechanisms causing disturbance in Ca++ homeostasis in malarial parasites remained 
unknown for almost two decades. 
 Some possible mechanisms are:  
1.  Ca++ based signaling pathway used by plasmodium parasites results in reduced 
calcium status, especially intracellular calcium, but not Ca++ found in body fluids. 
Environment of the host cell cytoplasm is disturbed by this. But how the protozoa 
achieved the calcium homeostasis – was unanswered.  
 
2. Plasmodium Falciparum infected red blood cells show increased permeability for 
calcium. The magnitude of the increase is greater than that normally require activating 
the Ca++ dependent K+ channel. Some studies showed that Falciparum 
infectionincreases the influx of Ca++ to over 1mmol which is much higher than the 
normal values. The pathway responsible for the enhanced influx was expressed at 
approximately 30 hrs post invasion.  
 
3. Calcium dependent Transglutaminase activity that reduces the calcium level is found 
increased, in some studies. This decrease is found simultaneous with maturation of the 
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parasite. The effect is maximum when the trophozoitesare 48 hrs old and at that time 
most of the calcium is found in the parasite.  
 
4. Ionized calcium “set point for basal PTH secretion is decreased in malaria. But a 
normal PTH response to acute hypocalcaemia in malaria skeletal resistance may attenuate 
the effect of the PTH response but patients with malaria appear relatively resistant to the 
calcium chelating effects of citrated blood products.  
 
5. Some study showed that serum calcium is utilized by the parasite and this creates drug 
resistance in parasites. Sometimes, Chloroquine resistance is seen in Plasmodium 
Falciparum because of intracellular calcium utilization. This causes decreased calcium 
status in patients as well as drug resistance. The Chloroquine resistance is totally reversed 
when the channels of calcium were blocked with Verapamil & Fantofarone. Verapamil 
appeared 2to 3 times more potent than Fantofarone in reversing the drug resistance.  
 
6. Disturbed Parathyroid hormone profile has also contributed to the lowered Calcium 
Status.  ‘Sick euparathyroid syndrome’  is defined as  a state in which the parathyroid 
response to Hypocalcemia  remains  depressed during active infection, with recovery of 
the  glandular function as the parasitemia gets cleared. 
 
7. Another possible cause for malaria-induced Hypocalcemia relates to the changes in 
phosphate metabolism.  Hypophosphatemia in malaria occur as a result of lowered renal 
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threshold for phosphate. Hypercalcuria that occur along with Hypophosphatemia also 
contributes to hypocalcemia . Hypophosphatemia can cause encephalopathy, depressed 
leucocyte function, increased susceptibility to Gram-negative infections, platelet 
dysfunction, coagulation abnormalities, and hemolytic anemia are associated with 
hypophosphatemia  . These abnormalities are also seen in severe and complicated 
malaria. 
 
8. Mild asymptomatic hypomagnesemia is seen  in malaria. Hypomagnesemia impair the 
release of parathormone by the parathyroid gland and blunt the tissue response to 
parathormone. This inturn results in Hypocalcemia. 
 
  Many studies found out that hypocalcemia has prognostic value in malaria as it may 
indicate complicated malaria or heavy parasitemia and it’s return to normal serum level 
may indicate clinical recovery and parasite clearance. 
 
Diagnosis of malaria 
Demonstration of parasites 
Malaria is diagnosed by thedemonstrating asexual forms of the parasite in stained 
peripheral-blood smears. In case of a negative blood smear, repeat smears should be 
made if there is high degree of suspicion. Of the Romanowsky stains, Giemsa atpH 7.2 is 
preferred.  Field’s, Wright’s, or Leishman’s stain can alsobe used. Both thin and thick 
blood smears should be made and examined. The thin blood smear should be fixed in 
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anhydrous methanol, and stained. The RBCs in the tail of the film should then be 
examined under oil immersion (×1000magnification). The number ofparasitized 
erythrocytes per 1000 RBCs expresses the level of parasitemia in the blood. The thick 
blood film should be of uneven thickness. The smear should be dried thoroughly and 
stained without fixing. As many layers of erythrocytes overlie one another and are lyses 
during the staining procedure, the thick film concentrate the parasites (by 40- to 100-
foldcompared with a thin blood film) and thus increasing diagnostic sensitivity.Both 
parasites and white blood cells (WBCs) should be counted, andthe number of parasites 
per unit volume is calculated from the total leukocyte count. A  WBC count of 8000/μL is 
assumed, as an alternative methode.This figure is converted to the number of parasitized 
erythrocytespermicro liter. A minimum of 200 WBCs/hpf should be counted.The 
relationship between parasitemiaand prognosis is complex; in general,risk of dying is 
increased in patients with >105 parasites/μL .But nonimmunepatients may die with much 
lower counts, and partially immune persons may tolerateparasitemia levels many times 
higher withonly minor symptoms. Predominanceof more mature P. falciparumparasites 
(i.e., >20% of parasites with visiblepigment) in the peripheral-blood filmor the presence 
of phagocytosed malarial pigment in >5% of neutrophils. Indicates poor prognosis in 
severe malaria.Gametocytemia peaks1 week after the peak of asexual parasites in P. 
falciparum infections. Because the mature gametocytes of P. falciparumare not affected 
by most antimalarialdrugs, their persistence cannot be taken as the evidence of drug 
resistance. Phagocytosedmalarial pigment is sometimes seen insideperipheral-blood 
monocytes or polymorphonuclearleukocytes and may provide a clue to recent infection if 
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malaria parasites are not detectable. After the clearance of the parasites, this 
intraphagocyte malarial pigment often evident for several days in the peripheral blood or 
for longer in bone marrow aspirates or smears of fluid expressed after intradermal 
puncture. More rapid diagnosis of malaria (but not speciation of the infection) in patients 
with low-level parasitemia can be done by Staining of parasites with the fluorescent dye 
acridine orange. Interpretation of blood smear films requires someexperience because 
artifacts are common. 100–200 fields should be examined under oil immersion before a 
thick smear is judged to be negative. In hightransmission areas, the presence of up 
to10000 parasites/μL of blood may be toleratedwithout symptoms or signs in 
partiallyimmune individuals. So detection of malaria parasites is sensitive in these areas 
buthas low specificity in identifying malaria asthe cause of illness. Low-density 
parasitemia iscommon in other conditions causing fever. 
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Figure.2 thin blood smear of plasmodium falciparum: A-young trophozoite, B-old 
trophozoite, C-pigments in polymorphonuclear cells and trophozoite, D-mature schizonts, 
E-female gametocyte, F-male gametocyte 1 
 
Rapid, simple, sensitive, and specific antibody-based diagnostic stick or card tests 
thatdetect P. falciparum –specific, histidine-richprotein 2 (PfHRP2) or lactate 
dehydrogenaseantigens in finger-prick blood samples are now being used widely in 
control programs. Falciparum malaria can be distinguished from the less dangerous 
malarias by some of these rapid diagnostic tests (RDTs) carry a second antibody. 
PfHRP2-based tests are found positive for several weeks after acute infection. This 
feature is a disadvantage in high-transmission areas where infections are frequent but is 
of value in the diagnosis of severe malaria in patients who have taken antimalarial drugs 
and cleared peripheralparasitemia (but in whom the PfHRP2 test remains strongly 
positive). RDTs are replacingmicroscopy in many areas because of theirsimplicity and 
speed, but they are relativelyexpensive and do not quantify parasitemia. 
Laboratory findings 
Normochromic, normocytic anemia is usual. The leukocyte count is generally normal, 
although it may be raised in very severe infections.Monocytosis, lymphopenia, and 
eosinopenia,with reactive lymphocytosis and eosinophilia can be seen in the weeks after 
the acute infection. The erythrocyte sedimentation rate, plasma viscosity, 
And levels of C-reactive protein and other acute-phase proteins are high. The platelet 
count is usually reduced to ~10 5 /μL. Prolonged prothrombin and partial thromboplastin 
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times and more severe thrombocytopenia are noted in severe infection. Levels of 
antithrombin III are reduced even in mild infection. Plasma concentrations of 
electrolytes, blood urea nitrogen (BUN), and creatinine are usually normal in 
uncomplicated malaria. 
Findings in severe malaria may include metabolic acidosis, with low plasma 
concentrations of glucose, sodium, bicarbonate, calcium, phosphate, and albumin 
together with elevations in lactate, BUN, creatinine, urea, muscle and liver enzymes, and 
conjugatedand unconjugated bilirubin. Hypergammaglobulinemia is usual in immune and 
semi-immune subjects. Urinalysis generally gives normal results. In adults and children 
with cerebral malaria, the mean opening pressure at lumbar puncture is ~160 mm of 
cerebrospinal fluid (CSF).usually the CSF is normal or has a slightly elevated total 
protein level [<1.0 g/L (<100 mg/dl)] and cell count (<20/μL). 
 
Treatment of malaria  
When a patient in or from a malarious areapresents with fever, thick and thin blood 
smears should be prepared and examined immediatelyto confirm the diagnosis and 
identify the species of infecting parasite. Repeat blood smears should be performed at 
least every12–24 h for 2 days if the first smears are negative and malaria is strongly 
suspected. Alternatively, a rapid antigen detection cardor stick test can be performed. 
Parenteral antimalarial therapy should be given to patients with severe malaria or those 
unable to take oral drugs. The organism should be considered resistant if there is any 
doubt about the resistance status of the infecting organism. Antimalarial drug 
29 
 
susceptibility testing can be performedbut is rarely available and yields results too slowly 
to influence the choice of treatment. Several drugs are available for oral treatment. The 
choice of drug depends on the likely sensitivity of the infectingparasites. There is  
increasing evidence of Chloroquine resistancein P. vivax (from parts of Indonesia, 
Oceania, eastern andsouthern Asia, and Central and South America).Still  
Chloroquineremains the treatment of choice for the non-falciparum malarias(P . vivax , P 
. ovale , P . malariae , P . knowlesi) except in Indonesiaand Papua New Guinea, where 
high levels of resistance inP. vivax are prevalent.The treatment of falciparum malaria has 
changed radicallyin recent years. In all endemic areas, the World HealthOrganization 
(WHO) now recommends artemisinin-basedcombinations as first-line treatment for 
uncomplicated falciparum malaria. 
Uncomplicated malaria 
  Chloroquine sensitive strains are treated with chloroquine (10mg/Kg stat followed by 10 
mg/Kg at 24hrs and 5 mg/kg at 48 hrs). Primaquine at a dose of 0.25mg/Kg body weight 
od for 14 days, is used for the radical treatment of vivax malaria.  
   Uncomplicated falciparum malaria is treated with artemether-lumefantrene(1.5/9 
mg/Kg body weight at 0 and 8 hrs on day 1 and bd on day 2 and 3). Artesunate(4mg/Kg 
od for 3days) plus sulphadoxine(25 mg/Kg body weight)/pyramethamine(1.25 mg/Kg 
body weight) as a single dose can also be used for the treatment of uncomplicated 
falciparum malarial fever. 
Complicated malaria 
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One of the following regimens are commonly used for the treatment of complicated 
malarial infection. 
1. Artesunate(2.4 mg/Kg bodyweight iv stat followed by 2.5 mg/Kg body weight at 
12 and 24 hours and daily) 
2. Artemether(3.2 mg/Kg body weight im stat followed by 1.6 mg/Kg body weight ) 
3. Quinine dihydrochloride(20 mg/Kg body weight infused over 4 hours followed by 
10 mg/Kg infused over 2-8 hours.) 
 
Hypocalcemia 
Causes of Hypocalcemia 
Low Parathyroid Hormone Levels (Hypoparathyroidism) 
Parathyroid agenesis 
      Isolated 
      DiGeorge syndrome 
Parathyroid destruction 
     Surgical 
     Radiation 
     Infiltration by metastases or systemic diseases 
     Autoimmune 
Reduced parathyroid function 
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     Hypomagnesemia 
     Activating CaSR mutations 
 
High Parathyroid Hormone Levels (Secondary Hyperparathyroidism) 
     Vitamin D deficiency or impaired 1,25(OH)2D production/action 
     Nutritional vitamin D deficiency (poor intake or absorption) 
     Renal insufficiency with impaired 1,25(OH)2D production 
     Vitamin D resistance, including receptor defects 
Parathyroid hormone resistance syndromes 
      PTH receptor mutations 
     Pseudohypoparathyroidism (G protein mutations) 
Drugs 
     Calcium chelators 
      Inhibitors of bone resorption (bisphosphonates, plicamycin) 
      Altered vitamin D metabolism (phenytoin, ketoconazole) 
Miscellaneous causes 
      Acute pancreatitis 
      Acute rhabdomyolysis 
      Hungry bone syndrome after parathyroidectomy 
     Osteoblastic metastases with marked stimulation of bone formation 
     (prostate cancer) 
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Clinical features 
Patients with Hypocalcemia remain asymptomatic if the decreases in serum calcium are 
relatively mild and chronic. Severehypocalcemia may present with life-threatening 
complications. Moderate to severe hypocalcemia is associated with paresthesias, usually 
of the fingers, toes, and circumoralregions. It occurs as a result of 
increasedneuromuscular irritability. Chvostek’s sign (twitching of the circum oral 
muscles in response to gentle tapping of the facial nerve just anterior to the ear) may be 
elicited in hypocalcemia. Inflation of a blood pressure cuff to 20 mmHg above the 
patient’s systolic blood pressure for 3 min may induce carpopedal spasm (Trousseau’s 
sign). Severe hypocalcemia can induce seizures, carpopedal spasm, bronchospasm, 
laryngospasm, and prolongation of the QT interval. 
 
Treatment 
Acute, symptomatic hypocalcemia is initially managed with calcium gluconate, 10 ml 
10% wt/vol (90 mg or 2.2 mmol) intravenously, diluted in 50 ml of 5% dextrose or 0.9% 
sodium chloride, given intravenously over 5 min. A constant intravenous infusion 
(typically10 ampoules of calcium gluconate or 900 mg of calcium in 1 L of5% dextrose 
or 0.9% sodium chloride administered over 24 h) should be given to those with ongoing 
hypocalcemia. 
Accompanying hypomagnesemia, if present, should be corrected with appropriate 
magnesium supplementation.Calcium supplements (1000–1500 mg/d elemental calcium 
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in divided doses) and either vitamin D 2 or D 3 (25,000–100,000 Udaily) or calcitriol 
[1,25(OH) 2 D, 0.25–2 μg/d are used to correct chronic hypocalcemia due to 
hypoparathyroidism]. Vitamin D deficiency, however, is best treated using vitamin D 
supplementation. Dose of vit D depends on the severity of the deficit and the underlying 
cause. Thus, nutritional vitamin D deficiency generally responds to relatively low doses 
of vitamin D (50,000 U, 2–3 times per week for several months),while vitamin D 
deficiency due to malabsorption may require much higher doses (100,000 U/d or more). 
The treatment goal is to bring serum calcium into the low normal range and to 
avoidhypercalciuria, which may lead to nephrolithiasis. 
 
Studies regarding hypocalcemia in malaria 
 Prabha M R et al (1998) conducted a study on clinical implication of hypocalcemia in 
malaria. She took 60 adult cases of malaria and estimated serum calcium in them to find 
out prevalence and clinical implications of hypocalcemia in different types of 
malaria.ECG was taken in all patients to look for QTc prolongation, which is found in 
hypocalcemia.27 out of 60 patients (45%) were found to have hypocalcemia. 88.24% 
patients with complicated malaria had hypocalcemia whereas hypocalcemia was 
detectedin only 27.19 patients with uncomplicated malaria.Mean serum calcium level in 
complicated malaria was (7.4 +/- 0.98mg %) against (8.4 /- 0.4mg %) in uncomplicated 
malaria. She noted significant correlation between degree of hypocalcemia and QTc 
prolongation with a significant p value of <0.01. 3 patients with long QTc died of 
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hypotension,bradycardia and heart block after quinine therapy.She also stated that there is 
an inverse relationship between serum calcium level and parasite load (p<0.05). Serum 
calcium was found to return to normal with clinical recovery and lowering of parasite 
load. Though exact cause of hypocalcemia in malaria could not be found out,it was 
attributed to renal failure, hypomagnesemia and parathyroid dysfunction. She concluded 
that hypocalcemia in malaria is not uncommon and it can be used as a prognostic 
indicator in complicated malaria as it can cause cardiac conduction abnormalities and 
death, and serum calcium level returns to normal with clinical recovery and parasite 
clearance. 
 
 Dr Seema Mishra et al(2013)conducted a study on malaria precipitated hypocalcemia 
and related complications. 70 case of malaria were studied to find out the clinical and 
prognostic implication of hypocalcemia and corrected QT interval prolongation in 
malaria. Parasite species and parasite load were detected by peripheral smear. 30 
patients (18 complicated and 12 uncomplicated) out of 70 had P.falciparam malaria. 30 
patients were of  P.vivax malaria while 10 had mixed infection(both P.falciparum and 
P.vivax). Hypocalcemia was noted in 44 patients and all of them had prolonged QTc. 
Out of 14 patients presented with convulsions, 14 patients had prolonged QTc and 10 
patients had hypocalcemia. Out of   8 patients presented with muscle spasm,  6 patients 
had prolonged QTc and 5  patients had hypocalcemia. 54 patients had cerebral malaria; 
of which  23had hypocalcemia as well as prolonged QTc , 15  developed renal failure 
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and  14 patients had high parasitemia. 2  patients with hypocalcemia and prolonged QTc  
died of hepatorenal syndrome. Patients with complicated  falciparum malaria were 
reported to have  a mean parasite load, QTc interval and serum calcium ,of  (3.07 +/- 
1.2), (0411 +/- 0.038) sec  and (7.06 +/- 0.77 ) mg% respectively , whereas  it was (1.9 
+/- 0.53) , (0.512 +/- 0.033) sec and (7.02 +/- 0.49 ) mg% respectively in complicated 
mixed infection. It was (1.04 +/- 0.61),(0.435 +/- 0.035) sec and (8.07 +/- 1.07) mg% in 
uncomplicated falciparum malaria and (1.43 +/- 0.58),(0.403 +/- 0.019)sec and (8.68 +/- 
03)mg%  in vivax malaria. She concluded that hypocalcemia is a feature of 
severe/complicated malaria as it had a good correlation with parasite load and 
complications.  According to her,hypocalcemia also had a prognostic value in malaria as 
serum calcium level returns to normal with clinical recovery. 
 
Ankush agarwal et al(2018) carried out a study on effect of  malarial parasitemia on 
serum electrolytes in south east Rajasthan. Serum calcium level was one of the 
parameters studied. 256 patients with malaria infection (153 females and 103 males) were 
studied. 215 out of 256 patients were from rural areas whereas 41 were from urban 
regions. 144 patients had P.falciparum malaria whereas 86 patients were having P.vivax 
malaria. 26 patients had mixed infection(P.vivax and P.falciparum).  Serum 
sodium,potassium and calcium were measured in each patient. Hypocalcemia(<9 mg%) 
was detected in 94 patients with falciparum malaria,43 patients with vivax malaria and 18 
patients with mixed infection. 45  patients with falciparum malaria,41 patients with vivax 
malaria and 7  patients with mixed infection had normal serum calcium(9-11mg%). . 5  
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patients with falciparum malaria,2 patients with vivax malaria and 1  patients with mixed 
infection had hypocalcemia(>11mg%). 
 
Sony CL et al (2000)did a study  on prognostic implication of hypocalcemia and QTc 
interval in malaria. 100 confirmed malaria cases were included in the study. Out of 100 
patients, 50 patients(38 complicated and 12 uncomplicated) were P.falciparum positive 
cases; 40 patients were of vivax malaria and 10 patients were having mixed infection. 26 
patients were reported to have hypocalcemia. All the patients with hypocalcemia had 
prolonged QTc. 10 patients developed convulsions; all of them were having prolonged 
QTc and 8 of 10 patients had hypocalcemia. Out of 8 patients who presented with muscle 
spasms , 6 patients had QTc prolongation and 4 patients had hypocalcemia. Out of 34 
cases of cerebral malaria, 18 developed hypocalcemia as well as QTc prolongation,12 of 
them developed acute renal failure and 14 had high parasitemia. 4 patients with both 
hypocalcemia and QTc prolongation died of hepatorenal syndrome during the study 
period. The mean parasite load, QTc interval and serum calcium were 2.69 +/- 1.0 , 0.468 
+/- 0.055 sec and 8.16 +/- 0.97 mg% respectively  in complicated falciparum infection; 
1.6 +/-  0.55 , 0.442 +/- 0.043 sec and 8.72 +/- 0.97 mg% respectively in mixed infection 
; 1.33 +/- 0.52 ,0435 +/- 0.035 sec and 9.77 +/- 1.34 mg%  respectively in uncomplicated 
falciparum malaria ; 1.35 +/-0.58, 0.403 +/- 0.019 sec and 9.68 +/- 0.99 mg% 
respectively in vivax infection. In conclusion, hypocalcemia and QTc prolongation was 
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found significantly in complicated falciparum and mixed infection as compared to 
uncomplicated falciparum and vivax malarial infection(p<0.05) 
 
Asima rani et al (2005) conducted a study on electrolyte disturbance on different types 
of malarial infection. 173 patients were studied. Out of 173 patients 73 were malarial 
patients and 100 were non malarial healthy individuals. Study group-malarial patients-
were categorized into two groups based on causative species of plasmodium-those with 
P.falciparum  or P.vivax infection. Mean serum level of sodium,potassium,calcium and 
magnesium are measured in all 173 patients. Serum calcium level in P.falciparum, 
P.vivax infection and normal healthy individual were 6.52 +/- 1.09 mg% ,6.07 +/- 1.32 
mg% and 9.08 +/- 4.48 mg% respectively.  They had also looked for any gender wise 
difference in serum calcium level in different malarial infection. Mean serum calcium in 
P.falciparum infection, P.vivax infection and healthy individuals in male population were 
6.54 +/- 1.05 mg% , 5.93 +/- 1.29 mg% and 8.96 +/- 4.61 mg% respectively whereas it 
was 6.43 +/- 1.33 mg%,6.58 +/- 1.48 mg% and 9.09 +/-4.34 mg% respectively in female 
population. She concluded that there is no significant difference in the  prevalence of 
hypocalcemia in falciparum and vivax malaria. No variation in level of serum calcium 
was noted due to gender difference. 
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Davis TM et al (1993) conducted a study on serum calcium, serum and intracellular 
phosphate and serum parathormone concentration in acute malaria. He had measured 
serum ionized calcium and intracellular phosphate in 18 malarial patients(10 with 
P.falciparum and 8 with P.vivax malaria) and 10 healthy individuals. 6 out of 18 malarial 
patients(4 falciparum,2vivax) were having low serum  ionized calcium at the time of 
admission and a further 6 patients(3 falciparum,3 vivax ) developed hypocalcemia during 
treatment. Development of hypocalcemia was prominent in those with P.falciparum 
infection. Serum parathormone level was found to be depressed in malarial fever , 
especially in falciparum malaria.  
 
T M E Davis et al (1991) studied about calcium and phosphate metabolism in acute 
falciparum malaria. He measured serum calcium and phosphate  in 172 Thai adults ,at the 
time of presentation. They were of mean age 35 and 87 were males and 85 were females. 
A subgroup of 10 severely ill patients was studied prospectively for any changes in serum 
calcium and phosphate during treatment. 61 patients in cross sectional study developed 
hypocalcemia and he could not find out difference in degree of hypocalcemia between 
those with uncomplicated and complicated malaria. 6 out of 10 patients ,studied 
prospectively developed hypocalcemia during treatment. Serum parathormone  level was 
also found low in these patients. Serum phosphate concentration was low in 74 patients. 
He concluded that mild hypocalcemia in malaria is common regardless of  disease 
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severity. According to him, low serum parathormone level contributes to hypocalcemia in 
acute malaria. 
 
J C Petithory et al (1985) did a study on  hypocalcemia in malaria-study of correlation 
with other parameters. He measured serum calcium and albumin 26 non Africans with 
malaria. They had meanserum calcium of 8.5 mg% and average hypoalbuminemia of 3.7 
mg%. he also measured serum calcium level in 30 each Africans with and without 
malaria. Those with malaria had average calcium of 8.75 mg% whereas those without 
malaria had average serum calcium of 9.15mg%. 
 
Ayoola  et al (2005) carried out a study on serum calcium and phosphatelevel in Nigerian 
children with malaria. He detected serum calcium and phosphate level in 39 children with 
malaria(6 complicated and 33 uncomplicated) and 39 healthy children. Hypocalcemia 
was detected in 23.1 % of malarial cases and 5.1% of controls. 38.5% of cases and 15.4% 
of controls had Hypophosphatemia. With these findings he concluded that hypocalcemia 
and Hypophosphatemia are associated with malaria in Nigerian children. 
 
Sudhindra Rao Mananje et al (2017) conducted a study on QTc prolongation as an 
indicator of complications in malaria. 92 patients were included in the study. 12 patients 
had prolonged QTc. 10 out of 12 patients had associated complications. Of 80 patients 
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with normal QTc ,only 17 patients developed complications. Hypokalemia and 
hypocalcemia are the two dyselectrolemia that cause QTc prolongation. Mean serum 
potassium level was found to be low in those with QTc prolongation. Serum calcium 
level was not considered in this study. He concluded that, QTc prolongation is 
significantly associated with P.vivax malaria and AKI in malaria. So, malaria patients 
with QTc prolongation should be carefully monitored for complications. 
 
Mohapathra M K et al (2009) studied about parathyroid dysfunction in complicated 
falciparum malaria. 42 patients with complicated falciparum malaria ,10 patients with 
uncomplicated falciparum malaria and 10 healthy individuals were included in the study. 
Serum calcium,magnesium,phosphate and parathormone level were measured. The study 
revealed the occurrence of hypocalcemia,hypomagnesemia and hypophosphatemia in 
malaria, regardless of disease severity.  Patients had  low parathormone level, in spite of 
hypocalcemia. It can be explained by low ionized calcium set point for parathormone 
secretion  which occurs as a result of  malaria induced parathyroid gland dysfunction. 
 
B A Iwalokun  et al (2017) did a study of calcium dynamics in infected erythrocytes of 
Nigerian children with plasmodium falciparum malaria. He carried out this study to find 
out the ghost membrane Ca 2+ ATPase  activity in infected erythrocytes and its 
relationship with intracellular calcium concentration, parasite maturation and age. 32 
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children of mean age 5.8 years, with plasmodium falciparum  parasitemia  were selected 
for the study. Ghost membrane was  prepared from the blood sample collected from these 
children by isotonic hemolysis and resealing. Ghost membrane Ca 2+ATPase 
activity(micromole of inorganic phosphate liberated from ATP substrate per hour) and 
intracellular calcium content in RBC were detected by  spectrophotometric method.  The 
infected erythrocytes were harboringring form(56.3%), schizonts/trophozoites(34.4%), 
and gametocytes(9.3%).  A significant 1.9 – 3.9 fold increase in intracellular calcium 
concentration and 14. – 2.0 decrease in ghost membrane Ca 2+ ATPase activity were 
noted in infected erythrocytes ,as compared to control. This inverse relationship was 
found to be prominent ,with maturation of parasites.  He concluded that  decreased Ca 
2+ATPase activity is responsible for increased concentration of intracellular calcium that 
is essential for maturation of parasites within the RBCs. So , this intracellular  shift  of 
calcium may contribute to development of hypocalcemia in malaria. 
 
Zyed ahammed zaki et alin his article on atypical manifestations of malaria stated that 
mild asymptomatic cases of  hypocalcemia are commonly seen in one – third of cases of 
malaria. According to him sick euparathyroid syndrome is the main cause of 
hypocalcemia in acute malaria. He said that, hypophosphatemia and mild asymptomatic 
hypomagnesemia occurring in acute malarial infection also contribute to hypocalcemia. 
Lowered renal threshold for phosphate was considered as the cause of hypophosphatemia 
in malaria. Hypophosphatemia in turn cause hypercalcuria and hypocalcemia. 
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Mohsin Ali Baloch et al (2018) did a study on determination of serum calcium in 
patients with malaria by flame photometer. 50 each  patients and controls were studied. 
He detected hypercalcemia in malarial patients.   
 
Maitland K et al (2005) conducted a study on perturbations in electrolytes levels in 
Kenyan children with severe malaria complicated by acidosis. 52 kenyan children with 
complicated malaria (impaired consciousness or deep breathing) ,complicated by 
acidosis(base deficit >8 mmol/l) were included in the study. Serum 
potassium,calcium,magnesium and phosphate levels were measured in these children. 
Mild to moderate hypercalcemia was common, particularly in those presented with severe 
malaria. Hypocalcemia was infrequent (<5%)  at point of time. Hyperkalemia 
complicated malaria in 9 patients; 7 of them died. Hypokalemia , hypomagnesemia and 
hypophosphatemia were also uncommon(<7%) at the time admission, but 30 % of 
patients developed the same in 24 hours. They have noted an increased  Intraerythrocytic 
calcium levels  in PRBCs.  So, authors have suggested that increase in calcium levels 
resulted from the release of intracellular calcium secondary to the erythrocyte lysis in 
malaria. Association of  hypercalcemia and severe malarial anemia, supported  the 
inverse linear relationship between plasma calcium and hemoglobin levels. 
ie;hypercalcemia is noted in those with severe  hemolytic anemia.  In addition, the  
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acidosis in severe malaria can displace the  ionized  calcium bound to  albumin and cause 
hypercalcemia. 
 
Zayed ahammed zaki et al (2010)had reported an unusual presentation of malaria as 
tetany. 12 years old boy was admitted with complaints of high grade fever with chills and 
rigor and painful , intermittent muscle spasm of left foot for one day. His dietary history 
was normal with adequate calcium intake. Physical examination reveled 
tachycardia,tachypnoea and a normal blood pressure. Liver was tender and palpable 4 cm 
below the RCM. Spleen was palpable 3 cm below the LCM. Peripheral smear showed 
plasmodium falciparum. There was anemia and thrombocytopenia. Serum calcium at the 
time of admission was 7.1 mg% . Serum albumin was low(3mg%). Serum phosphate and 
magnesium was within normal limits. ECG was normal. The patient was treated with iv 
artesunate, calcium phosphate and magnesium infusion. Patient became asymptomatic on 
day 4 of the treatment.  
 
Akinyele akinlade et al reported a case of symptomatic hypocalcemia associated with 
acute severe malaria. 25 years old female presented with 5 day history of high grade fever 
with chills and rigor. She also had post prandial vomiting,epigastric pain, generalized 
tiredness, malena and cramps in hands and feet.  No past history of cramps. She was 
diagnosed to have plasmodium falciparum malaria. Carpopedal spasm was noted on 
physical examination. Total calcium at the time of admission was low(1.37 mmol/l). 
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Total calcium raised to 1.8 mmol/l on next day, but still below normal. Serum albumin 
was 3.05gm%. ECG showed APCs and prolonged QTc. She was treated with iv 
artesunate and calcium gluconate. Serum calcium came to normal(2.16 mmol/l) on fifth 
day of admission and she became asymptomatic. 
 
Lacunae in knowledge 
 There are very few studies in the literatures regarding  prevalence and clinical 
implication of hypocalcemia in malaria.  
 There is paucity of studies conducted on this topic in this part of the country that 
makes this study very pertinent. 
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                                        AIMS AND OBJECTIVES 
Aim of the study 
The aim of present study is to determine the prevalence and clinical profile of 
hypocalcemia in different types of malarial fever. 
Objectives 
Primary objects: 
To evaluate the prevalence of hypocalcemia in malarial fever. 
Secondary objects:  
To study association between 
1. Serum calcium level and types of malaria. 
2. QTc prolongation and types of malaria. 
3. Clinical manifestation of hypocalcemia and types of malaria. 
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MATERIALS AND METHODS 
Type of Study:  cross sectional  study. 
Study center:Stanley Government Medical College, Chennai. 
Sample size: 110 
                     n= 4pq/d2 
                      p---45 %,  
                     q=100-p = 55% 
                     d --- error, taken as 10% for this study 
so,  n= 45*55/10*10 = 99  
non responsive rate is 10 %  
so, sample size =99 +9= 108 
so, final sample size is 110 
 (Ref: 1 .clinical implication of hypocalcaemia in malaria; journal of medical research, 
8/1/98: Prabha,M R Adhikari)          
Study duration: March 2018 to August 2018 (6 Months) 
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Inclusion criteria: 
Patients with acute febrile illness (less than 7 day’s duration) and peripheralsmear 
positivity for malarial parasite  
Exclusion criteria:   
1. Patients with fever more than 7days duration 
2. Patients who have undergone thyroid surgery 
3. Patients with chronic kidney disease 
4. Patients with chronic liver disease 
5. Patients with hypoalbuminemia 
 
METHODOLOGY 
All the patients admitted in the medicine wards in Stanley medical college hospital from 
March 2018, who are found positive for peripheral smear for malaria, were included in 
the study until the sample size of 110 is achieved.  Both thick and thin smear were done 
for diagnosing malaria. Thick smear gives a diagnosis of malaria whereas thin smear was 
done to identify the species of malaria. Serum calcium was measured in all the patients at 
the time of admission. No patient was included more than once. A detailed profoma/case 
report form was used for each patient, that included the following details. 
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 History and detailed clinical examination was done with special emphasis on signs 
and symptoms of complicated malaria and hypocalcaemia. Cerebral malaria, acute 
renal failure, ARDS, shock, severe anemia, hypoglycemia, DIC, jaundice and 
pulmonary edema were considered as complicated malaria for this study. 
Convulsions , carpopedal spasms,numbness, Trausseu’s sign and  Chevstok’s sign 
were considered as the clinical manifestation of hypocalcemia in this study. 
Malarial patients were stratified into 2 groups according to the severity of the 
disease – complicated and uncomplicated malaria. 
 Those with peripheral smear positivity for malaria  was taken as the cases of 
malarial fever and enrolled for the studies. Patients were stratified into 3 groups 
according to the species of plasmodium parasite causing the disease. Patients with 
P.falciparum infection, P.vivax infection and mixed infection(P.falciparum 
+P.vivax) constituted the 3 groups. 
 
 
(Malarial parasite (plasmodium vivax) ,detected in peripheral smear in a patient) 
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 Blood was collected from the patient for serum calcium at the time of admission 
and  within 7 days of onset of fever. Serum  calcium was measured in central lab 
by Arsenazo method (reference range-8.8-10.5mg/dl). Total serum calcium level 
was analyzed in each patients. Total calcium level of < 8.8 mg% was taken as 
hypocalcemia for this study. 
 ECG was taken for all patients at the time of admission. QT segment was analyzed 
in each patients. Normal QTc in an ECG is equal to less than 0.44 sec. QTc of 
duration > 0.44 sec was considered as prolonged QTc for this study. 
 
 
(ECG changes of hypocalcemia(QTc prolongation) detected in a patient) 
 
 Patients were also stratified into different groups according to sex and age ; age 
and sex wise distribution of hypocalcemia in malarial patients was also analyzed. 
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Human subject protection 
Full protocol along with proforma and informed consents was kept in institutional ethical 
committee and approval was obtained. 
Informed consent 
        Consent form was available in both English and Tamil. The  consent was obtained 
from all the participants and confidentiality was maintained. 
 
 
 
 
 
 
 
 
51 
 
                                  RESULTS 
Demography 
A total of 110 malarial fever patients were included in the study. 68patients  were males 
and 42 patients  were females. Out of 110 malarial cases 49 patients were infected with 
plasmodium falciparum. Of 49 falciparum malaria 15 patients presented with 
complicated malaria while 34 patients had uncomplicated malaria. Fifty out of 110 
patients were having vivax malaria. Ten out of 50 had complicated vivax malaria whereas 
40 patients had uncomplicated vivax malaria. Eleven out of 110 patients presented with 
mixed infection. Six patients with mixed infection had complicated malaria while 5 
patients had uncomplicated malaria. 
Prevalence of hypocalcemia in our study population 
   Out of 110 malarial cases 61 patients(55.5%) were found to have hypocalcemia. 49 
patients (44.5 %) presented with normal serum calcium level. 
Serum Calcium level N % 
Hypocalcemia 61 55.5% 
Normal 49 44.5% 
Total 110 100.0% 
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Comparison of prevalence of hypocalcemia in malaria in males and females 
 Out of 68 males with malaria 41 patients(60.3%) have hypocalcemia while 27 
patients(39.7%) didn’t have hypocalcemia. 20 out of 42 female patients(47.6%) 
developed hypocalcemia while 22 patients(52.4%) had normocalcemia. There was no 
statistically significant difference of prevalence of hypocalcemia in malaria between 
males and females. 
Gender 
Serum Calcium level 
Hypocalcemia Normal Total 
N % N % N % 
Male 41 60.3% 27 39.7% 68 100.0% 
Female 20 47.6% 22 52.4% 42 100.0% 
Total 61 55.5% 49 44.5% 110 100.0% 
 
Chi-Square Test Value p-value 
Pearson Chi-Square 1.689 0.194 
 
55%
45%
Prevalence of hypocalcemia 
Hypocalcemia
Normal
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Comparison of prevalence of hypocalcemia in complicated and uncomplicated 
malaria 
Out of 110 malarial cases 31 patients(28.18%) were having complicated malaria. 22 
patients(71%) out of 31 complicated malaria had hypocalcemia while 39 patients(49.4%) 
out of 79 uncomplicated malaria presented with hypocalcemia. 9 patients with 
complicated malaria (29%) had normal serum calcium.40 patients with  uncomplicated 
malaria(50.6%) had normal serum calcium. Hypocalcemia was found to be more 
prevalent in complicated malaria than uncomplicated malaria. The results were analyzed 
with Pearson chi square test and p- value was found to be significant(p value-0.040). 
Malaria complication 
Serum Calcium level 
Hypocalcemia Normal Total 
N % N % N % 
Complicated 22 71.0% 9 29.0% 31 100.0% 
Uncomplicated 39 49.4% 40 50.6% 79 100.0% 
Total 61 55.5% 49 44.5% 110 100.0% 
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Chi-Square Test Value p-value 
Pearson Chi-Square 4.205 0.040* 
*  p value <0.05 is significant 
 
 
 
 
 
 
 
Comparison of hypocalcemia in different species of malaria 
   Out of 49 cases of falciparum malaria 34 patients(69.4%) had hypocalcemia whereas 
30.6 % patients had normocalcemia. 22 patients with vivax malaria cases(44%) 
developed hypocalcemia whereas 56% vivax malarial patients were having 
normocalcemia. 5 (55.5%) out of 11 patients with mixed infection had hypocalcemia. 
Normocalcemia was noted in 6 patients(54.5%) with mixed infection. Hypocalcemia was 
found to be prevalent in falciparum malaria. Dates were analyzed with fisher’s exact test 
and found to be significant with p- value of <0.05(0.028) 
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
80.0%
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Complicated Uncomplicated
71.0%
49.4%
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Malaria species 
Serum Calcium level 
Hypocalcemia Normal Total 
N % N % N % 
Falciparum 
34 69.4% 15 30.6% 49 
100.0
% 
Vivax 
22 44.0% 28 56.0% 50 
100.0
% 
Mixed 
5 45.5% 6 54.5% 11 
100.0
% 
Total 
61 55.5% 49 44.5% 110 
100.0
% 
 
Chi-Square Test Value p-value 
Fisher's Exact Test 6.979 0.028* 
*  p value <0.05 is significant 
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Prevalence of hypocalcemia in different species of complicated and uncomplicated 
malaria 
     80% (12 patients) of complicated falciparum malaria cases had hypocalcemia. Only 
20%(3 patients) of complicated falciparum malaria patients had normocalcemia. 64.7% 
of patients with uncomplicated falciparum malaria presented with hypocalcemia whereas 
35.3% patients had normocalcemia. 60% of those with complicated vivax malaria had 
hypocalcemia. Normocalcemia was noted in 40% of patients with complicated 
hypocalcemia. 40% of patients with uncomplicated vivax malaria were having 
hypocalcemia whereas normocalcemia was reported in 60% patients with uncomplicated 
vivax malaria. Hypocalcemia was detected in 66.7% of those with complicated mixed 
infection while 33.3% of them had normocalcemia. Only 20% patients with 
uncomplicated mixed infection developed hypocalcemia. 80% of those with 
0.0%
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Types of malarial fever 
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uncomplicated mixed infection had normocalcemia. Prevalence of hypocalcemia was 
found to be highest in those with complicated falciparum malaria. There was a 
statistically significant difference in the prevalence of hypocalcemia between the 
different types of malaria.(p value – 0.004) 
Types of Malaria 
Serum Calcium level 
Hypocalcemia Normal Total 
N % N % N % 
Complicated falciparum 
12 80.0% 3 20.0% 15 
100.0
% 
Uncomplicated falciparum 
22 64.7% 12 35.3% 34 
100.0
% 
Complicated vivax 
6 60.0% 4 40.0% 10 
100.0
% 
Uncomplicated vivax 
16 40.0% 24 60.0% 40 
100.0
% 
Complicated mixed 
4 66.7% 2 33.3% 6 
100.0
% 
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Uncomplicated mixed 
1 20.0% 4 80.0% 5 
100.0
% 
Total 
61 55.5% 49 44.5% 110 
100.0
% 
 
Chi-Square Test Value p-value 
Fisher's Exact Test 11.369 0.004* 
*  p value <0.05 is significant 
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Types of Malaria 
Serum Calcium level 
Hypocalcemia Normal Total 
N % N % N % 
Complicated falciparum 
12 80.0% 3 20.0% 15 
100.0
% 
Uncomplicated falciparum 
22 64.7% 12 35.3% 34 
100.0
% 
Total 
34 69.4% 15 30.6% 49 
100.0
% 
 
Chi-Square Test Value p-value 
Fisher's Exact Test - 0.336 
 
  Prevalence of hypocalcemia in complicated falciparum malaria was found to be 80% 
while it was 64.7% in uncomplicated malaria. 20% of those with uncomplicated 
falciparum malaria and 35.3% of those with uncomplicated malaria had normocalcemia. 
The data were analyzed with fisher’s exact test. The difference in prevalence of 
hypocalcemia between complicated  and uncomplicated falciparum malaria was found to 
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be statistically insignificant. So, complexity of falciparum malaria doesn’t seem to have 
any influence on serum calcium level. This statistical insignificance may be because of 
the less number of falciparum malarial cases studied. 
Types of Malaria 
Serum Calcium level 
Hypocalcemia Normal Total 
N % N % N % 
Complicated vivax 
6 60.0% 4 40.0% 10 
100.0
% 
Uncomplicated vivax 
16 40.0% 24 60.0% 40 
100.0
% 
Total 
22 44.0% 28 56.0% 50 
100.0
% 
 
Chi-Square Test Value p-value 
Fisher's Exact Test - 0.302 
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     Prevalence of hypocalcemia in complicated vivax malaria was found to be 60% while 
it was 40% in uncomplicated vivax malaria. 40% of those with uncomplicated vivax 
malaria and 60% of those with uncomplicated vivax malaria had normocalcemia. The 
data were analyzed with fisher’s exact test. The difference in prevalence of hypocalcemia 
between complicated  and uncomplicated vivax malaria was found to be statistically 
insignificant(p-value-0.302). So, complexity of vivax  malaria doesn’t seem to have any 
influence on serum calcium level. This statistical insignificance may be because of the 
less number of vivax malarial cases studied. 
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Types of Malaria 
Serum Calcium level 
Hypocalcemia Normal Total 
N % N % N % 
Complicated mixed 
4 66.7% 2 33.3% 6 
100.0
% 
Uncomplicated mixed 
1 20.0% 4 80.0% 5 
100.0
% 
Total 
5 45.5% 6 54.5% 110 
100.0
% 
 
Chi-Square Test Value p-value 
Fisher's Exact Test - 0.242 
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      Prevalence of hypocalcemia in complicated mixed malaria was found to be 80% 
while it was 66.7% in uncomplicated mixed malaria. 20% of those with uncomplicated 
mixed malaria and 33.3% of those with uncomplicated mixed malaria had 
normocalcemia. The data were analyzed with fisher’s exact test. The difference in 
prevalence of hypocalcemia between complicated  and uncomplicated mixed malaria was 
found to be statistically insignificant(p value- 0.242). So, complexity of mixed malarial 
infection doesn’t seem to have any influence on serum calcium level. This statistical 
insignificance may be because of the less number of falciparum malarial cases studied. 
    Although a statistically significant difference was observed in the prevalence of 
hypocalcemia in complicated vs uncomplicated malaria,when cases were considered 
overall,such difference couldnot be established when individual species were considered.  
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Prevalence of QTc prolongation  in our  study population 
    54 (49.1%)  out of 110 malarial cases were found to have prolonged QTc. QTc was 
normal in 56 patients(50.9%). 
QTC status N % 
Prolongation 54 49.1% 
Normal 56 50.9% 
Total 110 100.0% 
 
 
 
    44 (81.5%) out of 54 patients with prolonged QTc had hypocalcemia while 10 (18.5%) 
patients had normocalcemia. 17 patients(30.4%) with hypocalcemia had normal QTc 
49.1%
50.9%
Prevalence of QTc prolongation 
Prolongation Normal
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interval. Both serum calcium and QTc were normal in 39 patients. QTc prolongation is 
found to be related to low serum calcium level. Data were analyzed with Pearson chi 
square test and found to be statisticallysignificant(p-value 0.001). 
 
QTC status 
Serum Calcium level 
Hypocalcemia Normal Total 
N % N % N % 
Prolongation 
44 81.5% 10 18.5% 54 
100.0
% 
Normal 
17 30.4% 39 69.6% 56 
100.0
% 
Total 
61 55.5% 49 44.5% 110 
100.0
% 
 
Chi-Square Test Value p-value 
Pearson Chi-Square 29.087 <0.001* 
*  p value <0.05 is significant  
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      72.1% of  patients with hypocalcemia were found to have QTc prolongation while  
27.9% patients had normal QTc interval. 20.4% patients with normocalcemia also 
developed QTc prolongation. 
Serum Calcium level 
QTC status 
Prolongation Normal Total 
N % N % N % 
Hypocalcemia 
44 72.1% 17 27.9% 61 
100.0
% 
Normal 
10 20.4% 39 79.6% 49 
100.0
% 
81.50%
30.40%
18.50%
69.90%
PROLONGATION NORMALQTc INTERVAL
HYPOCALCEMIA NORMAL
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Total 
54 49.1% 56 50.9% 110 
100.0
% 
 
 
Chi-Square Test Value p-value 
Pearson Chi-Square 29.087 <0.001* 
*  p value <0.05 is significant 
Comparison of prevalence of QTc prolongation  in complicated and uncomplicated 
malaria 
          64.5% patients with complicated malaria were found to have QTc prolongation 
while 35.5% patients didn’t have QTc prolongation. 43% patients with uncomplicated 
malaria  developed QTc prolongation. QTc interval was normal in 57% of patients with 
uncomplicated malaria. Prevalence of QTc prolongation was higher in complicated 
malaria than that in uncomplicated malaria. The data were analyzed with Pearson chi 
square test and found to be statisticallysignificant ,with a p value of  0.043. 
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Malaria complication 
QTC status 
Prolongation Normal Total 
N % N % N % 
Complicated 
20 64.5% 11 35.5% 31 
100.0
% 
Uncomplicated 
34 43.0% 45 57.0% 79 
100.0
% 
Total 
54 49.1% 56 50.9% 110 
100.0
% 
 
 
*  p value <0.05 is significant 
Chi-Square Test Value p-value 
Pearson Chi-Square 4.110 0.043* 
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Malaria 
complication 
Serum Calcium 
level 
QTC status 
Prolongation Normal Total 
N % N % N % 
Complicated Hypocalcemia 18 90.0% 4 36.4% 22 71.0% 
Normal 2 10.0% 7 63.6% 9 29.0% 
Total 20 100.0% 11 100.0% 31 100.0% 
Uncomplicated Hypocalcemia 26 76.5% 13 28.9% 39 49.4% 
Normal 8 23.5% 32 71.1% 40 50.6% 
Total 34 100.0% 45 100.0% 79 100.0% 
 
0.0%
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Malaria complication Chi-Square Test Value p-value 
Complicated  Fisher's Exact Test - 0.003* 
Uncomplicated  Pearson Chi-Square 17.542 <0.001* 
*  p value <0.05 is significant 
    90% of patients with QTc prolongation in complicated malaria were found to have 
hypocalcemia while 10% of  patients didn’t have hypocalcemia. Hypocalcemia was noted 
in 76.5% of patients with QTc prolongation in uncomplicated malaria. 23.5% of patients 
with QTc prolongation in uncomplicated malaria didn’t have hypocalcemia. It was found 
to be statistically significant. 
Comparison of prevalence of QTc prolongation  in different species of malaria 
      63.3% of patients with falciparum malaria were having prolonged QTc while it was 
normal in 36.7% cases of falciparum malaria. 38% of vivax malaria cases showed QTc 
prolongation while 62% patients had a normal QTc. QTc was prolonged in 36.4% 
patients with mixed malarial infection. QTc was normal in 63.6% cases of mixed 
infection.  Prevalence of QTc prolongation was highest in falciparum malarial fever. 
Pearson chi square test gave a p value of 0.029 which was statistically significant. 
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Malaria species 
QTC status 
Prolongation Normal Total 
N % N % N % 
Falciparum 
31 63.3% 18 36.7% 49 
100.0
% 
Vivax 
19 38.0% 31 62.0% 50 
100.0
% 
Mixed 
4 36.4% 7 63.6% 11 
100.0
% 
Total 
54 49.1% 56 50.9% 110 
100.0
% 
 
Chi-Square Test Value p-value 
Pearson Chi-Square 7.113 0.029* 
*  p value <0.05 is significant 
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Malaria 
species 
Serum Calcium 
level 
QTC status 
Prolongation Normal Total 
N % N % N % 
Falciparum Hypocalcemia 25 80.6% 9 50.0% 34 69.4% 
Normal 6 19.4% 9 50.0% 15 30.6% 
Total 31 100.0% 18 100.0% 49 100.0% 
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Vivax Hypocalcemia 16 84.2% 6 19.4% 22 44.0% 
Normal 3 15.8% 25 80.6% 28 56.0% 
Total 19 100.0% 31 100.0% 50 100.0% 
Mixed Hypocalcemia 3 75.0% 2 28.6% 5 45.5% 
Normal 1 25.0% 5 71.4% 6 54.5% 
Total 4 100.0% 7 100.0% 11 100.0% 
 
Malaria species Chi-Square Test Value p-value 
Falciparum Pearson Chi-Square 5.035 0.025* 
Vivax Pearson Chi-Square 20.109 <0.001* 
Mixed Fisher's Exact Test - 0.242 
*  p value <0.05 is significant 
    80.6% of patients with falciparum malaria and prolonged QTc were found to have 
hypocalcemia. Hypocalcemia was not detected in 19.4% of patients with falciparum 
malaria and QTc prolongation. 84.2% of vivax malarial cases were having QTc 
prolongation and hypocalcemia while 15.6% patients with QTc prolongation didn’t have 
hypocalcemia. 75% of patients with mixed infection had both QTc prolongation and 
hypocalcemia while 25% patient had QTc prolongation without hypocalcemia. 
Association between QTc prolongation and hypocalcemia was statistically significant in 
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falciparum and vivax malaria; but not in mixed infection. This statistical insignificance in 
mixed infection may be because of less number of mixed infection studied. 
Comparison of prevalence of QTc prolongation  in different species of complicated 
and uncomplicated malaria 
80% of patients with complicated falciparum malaria patients had prolonged QTc. 
Prevalence of QTc prolongation in complicated vivax malaria and complicated mixed 
malarial infection were 60% and 33.3% respectively. QTc was normal in 20%,67.5% and 
60% patients with uncomplicated falciparum malaria, uncomplicated vivax malaria and 
uncomplicated mixed malarial infection respectively. Complicated falciparum malarial 
patients were found to have the highest prevalence of QTc prolongation. It was found to 
be statistically significant. 
 
Types of Malaria 
QTC status 
Prolongation Normal Total 
N % N % N % 
Complicated falciparum 
12 80.0% 3 20.0% 15 
100.0
% 
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Uncomplicated 
falciparum 
19 55.9% 15 44.1% 34 
100.0
% 
Complicated vivax 
6 60.0% 4 40.0% 10 
100.0
% 
Uncomplicated vivax 
13 32.5% 27 67.5% 40 
100.0
% 
Complicated mixed 
2 33.3% 4 66.7% 6 
100.0
% 
Uncomplicated mixed 
2 40.0% 3 60.0% 5 
100.0
% 
Total 
54 49.1% 56 50.9% 110 
100.0
% 
 
Chi-Square Test Value p-value 
Fisher's Exact Test 12.056 0.027* 
*  p value <0.05 is significant 
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Types of Malaria 
QTC status 
Prolongation Normal Total 
N % N % N % 
Complicated falciparum 
12 80.0% 3 20.0% 15 
100.0
% 
Uncomplicated 
falciparum 
19 55.9% 15 44.1% 34 
100.0
% 
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Prevalence of QTC prolongation 
Complicated
Uncomplicated
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Total 
31 63.3% 18 36.7% 49 
100.0
% 
 
Chi-Square Test Value p-value 
Pearson Chi-Square 2.605 0.107 
 
 
        80% of patients with complicated falciparum malaria had prolonged QTc while 
55.9% of those with uncomplicated falciparum malaria developed QTc prolongation. 
Prevalence of normal QTc  in complicated and uncomplicated falciparum malaria was 
20% and 44.1% respectively. . The data were analyzed with fisher’s exact test. The 
80%
55.90%
20%
44.10%
COMPLICATED FALCIPARUM UNCOMPLICATED FALCIPARUM
QTc INTERVAL
PROLONGATION NORMAL
78 
 
difference in prevalence of QTc prolongation between complicated  and uncomplicated 
falciparum malaria was found to be statistically insignificant(p value- 0.107). So, 
complexity of falciparum malarial infection doesn’t seem to have any influence on QTc. 
This statistical insignificance may be because of the less number of falciparum malarial 
cases studied. 
Types of Malaria 
QTC status 
Prolongation Normal Total 
N % N % N % 
Complicated vivax 
6 60.0% 4 40.0% 10 
100.0
% 
Uncomplicated vivax 
13 32.5% 27 67.5% 40 
100.0
% 
Total 
19 38.0% 31 62.0% 50 
100.0
% 
 
Chi-Square Test Value p-value 
Fisher's Exact Test - 0.150 
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   60% of patients with complicated vivax malaria had prolonged QTc while 32.5% of 
those with uncomplicated vivax malaria developed QTc prolongation. Prevalence of 
normal QTc  in complicated and uncomplicated vivax malaria was 40% and 67.5% 
respectively. . The data were analyzed with fisher’s exact test. The difference in 
prevalence of QTc prolongation between complicated  and uncomplicated  vivax malaria 
was found to be statistically insignificant(p value- 0.150). So, complexity of vivax 
malarial infection doesn’t seem to have any influence on QTc. This statistical 
insignificance may be because of the less number of falciparum malarial cases studied. 
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Types of Malaria 
QTC status 
Prolongation Normal Total 
N % N % N % 
Complicated mixed 
2 33.3% 4 66.7% 6 
100.0
% 
Uncomplicated mixed 
2 40.0% 3 60.0% 5 
100.0
% 
Total 
4 36.4% 7 63.6% 11 
100.0
% 
 
Chi-Square Test Value p-value 
Fisher's Exact Test - 0.999 
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 80% of patients with complicated mixed malaria infection had prolonged QTc while 
55.9% of those with uncomplicated mixed malaria infection developed QTc prolongation. 
Prevalence of normal QTc  in complicated and uncomplicated mixed malaria infection 
was 20% and 44.1% respectively. . The data were analyzed with fisher’s exact test. The 
difference in prevalence of QTc prolongation between complicated  and uncomplicated 
mixed malaria infection was found to be statistically insignificant(p value- 0.999). So, 
complexity of mixed malarial infection doesn’t seem to have any influence on QTc. This 
statistical insignificance may be because of the less number of falciparum malarial cases 
studied. 
   Although a statistically significant difference was observed in the prevalence of QTc 
prolongation in complicated vs uncomplicated malaria,when cases were considered 
overall,such difference couldnot be established when individual species were considered. 
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Types of 
Malaria 
Serum Calcium 
level 
QTC status 
Prolongation Normal Total 
N % N % N % 
Complicated 
falciparum 
Hypocalcemia 10 83.3% 2 66.7% 12 80.0% 
Normal 2 16.7% 1 33.3% 3 20.0% 
Total 12 100.0% 3 100.0% 15 100.0% 
Uncomplicated 
falciparum 
Hypocalcemia 15 78.9% 7 46.7% 22 64.7% 
Normal 4 21.1% 8 53.3% 12 35.3% 
Total 19 100.0% 15 100.0% 34 100.0% 
Complicated 
vivax 
Hypocalcemia 6 100.0% 0 0.0% 6 60.0% 
Normal 0 0.0% 4 100.0% 4 40.0% 
Total 6 100.0% 4 100.0% 10 100.0% 
Uncomplicated 
vivax 
Hypocalcemia 10 76.9% 6 22.2% 16 40.0% 
Normal 3 23.1% 21 77.8% 24 60.0% 
Total 13 100.0% 27 100.0% 40 100.0% 
Complicated 
mixed 
Hypocalcemia 2 100.0% 2 50.0% 4 66.7% 
Normal 0 0.0% 2 50.0% 2 33.3% 
Total 2 100.0% 4 100.0% 6 100.0% 
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Uncomplicated 
mixed 
Hypocalcemia 1 50.0% 0 0.0% 1 20.0% 
Normal 1 50.0% 3 100.0% 4 80.0% 
Total 2 100.0% 3 100.0% 5 100.0% 
 
Types of Malaria Chi-Square Test Value p-value 
Complicated falciparum Fisher's Exact Test - 0.516 
Uncomplicated falciparum Pearson Chi-Square 3.825 0.051 
Complicated vivax Fisher's Exact Test - 0.005 
Uncomplicated vivax Pearson Chi-Square 10.940 0.001* 
Complicated mixed Fisher's Exact Test - 0.467 
Uncomplicated mixed Fisher's Exact Test - 0.400 
*  p value <0.05 is significant 
    Both QTc prolongation and hypocalcemia were noted in 83.3% ,78.9%, 100%, 76.9%, 100% 
and 50% of patients with complicated falciparum malaria,uncomplicated falciparum malaria, 
complicated vivax malaria, uncomplicated vivax malaria, complicated mixed infection and 
uncomplicated mixed infection. The association between QTc prolongation and hypocalcemia 
was found to be statistically significant only  in complicated and uncomplicated vivax malaria. 
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One-way ANOVA test  to compare mean values of serum calcium and QTc between 
different species of malaria 
    One way anova test was done to compare  the mean value of serum calcium and QTc 
between different types of malaria. Lowest mean serum calcium was observed in 
complicated falciparum malaria while highest mean serum calcium was observed in 
uncomplicated mixed malarial infection. Difference in mean serum calcium level in 
different types of malaria was found to have statistical significance with a pvalue of 
0.001. 
    Longest mean QTc  was observed in complicated falciparum malarial fever. 
Uncomplicated vivax malarial cases had shortest QTc. But, there was no statistical 
significance for the difference in mean QTc  between different types of malaria. P value 
was 0.143. 
Variables Types of malaria N Mean Std. Dev F-value p-value 
Serum 
Calcium 
Complicated falciparum 15 7.427 1.0368 
4.270 0.001* 
Uncomplicated 
falciparum 
34 8.065 1.2417 
Complicated vivax 10 8.230 1.1898 
Uncomplicated vivax 40 8.780 .9313 
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Complicated mixed 6 7.900 1.3461 
Uncomplicated mixed 5 8.940 .8649 
Total 110 8.284 1.1735   
QTC Complicated falciparum 15 .4587 .02031 
1.691 0.143 
Uncomplicated 
falciparum 
34 .4500 .02902 
Complicated vivax 10 .4520 .02616 
Uncomplicated vivax 40 .4385 .02445 
Complicated mixed 6 .4433 .03266 
Uncomplicated mixed 5 .4400 .02550 
Total 110 .4464 .02653   
*  p value <0.05 is significant 
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Tukey HSD Post Hoc Tests for Multiple Comparisons for Serum Calcium level 
    Since one  way anova test found out the statistical significance of difference in mean 
serum calcium level  between different types of  malaria, tukey HSD post hoc test was 
done to find out  most significant  difference in mean serum calcium level between 
different  types of malaria. It was found that, statistically significant difference in mean 
serum calcium was only observed  between complicated falciparum malarial and 
uncomplicated vivax malarial cases. 
 
 
Types of Malaria 
Mean 
Difference 
p-value 
Complicated falciparum Uncomplicated 
falciparum 
-.6380 0.420 
Complicated vivax -.8033 0.471 
Uncomplicated vivax -1.3533 0.001* 
Complicated mixed -.4733 0.947 
Uncomplicated mixed -1.5133 0.088 
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Uncomplicated 
falciparum 
Complicated vivax -.1653 0.998 
Uncomplicated vivax -.7153 0.065 
Complicated mixed .1647 0.999 
Uncomplicated mixed -.8753 0.555 
Complicated vivax Uncomplicated vivax -.5500 0.714 
Complicated mixed 
 
  
.3300 0.992 
Uncomplicated mixed 
 
-.7100 0.843 
Uncomplicated vivax Complicated mixed .8800 0.447 
Uncomplicated mixed -.1600 0.999 
Complicated mixed Uncomplicated mixed -1.0400 0.620 
*  p value <0.05 is significant 
Prevalence of symptomatic hypocalcemia(muscle spasm,convulsions and numbness) 
in study population 
     22 (20%) out of 110 patients with malaria had muscle spasm. 80% malarial cases 
didn’t have muscle spasm. 
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Muscle spasm N % 
Yes 22 20.0% 
No 88 80.0% 
Total 110 100.0% 
 
No  patients in the study population presented with convulsion. 
Convulsions N % 
Yes 0 0.0% 
No 110 100.0% 
Total 110 100.0% 
 
 Only 2 (1.8%) out of 110 patients with malarial fever presented with 
numbness.108(98.2%) patients didn’t have numbness. 
20%
80%
MUSCLE SPASM
YES
NO
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Numbness N % 
Yes 2 1.8% 
No 108 98.2% 
Total 110 100.0% 
 
Comparison of symptomatic hypocalcemia in different species of complicated and 
uncomplicated malaria 
60%(9 patients) of patients with complicated falciparum malaria presented with muscle 
spasm while 40%(6 patients) didn’t have muscle spasm. 5 (14.7%) out of 34 cases of 
uncomplicated falciparum malaria had muscle spasm while 29 (85.3%)patients didn’t 
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
40.0%
Muscle spasm Convulsions Numbness
20.0%
0.0%
1.8%
91 
 
have. 4(40%)out of  10 cases of complicated vivax malaria had muscle spasm while 6 
(60%)patients didn’t have it. Muscle spasm was observed in only 2 (5%) out of 40 cases 
of uncomplicated vivax malaria. 1(16.7%)out of 6 cases of complicated mixed malarial 
infection were having muscle spasm while 5(83.3%) patients didn’t have it. 1 (20%) out 
of 5 cases of uncomplicated mixed infection had muscle spasm while 4 (80%) out of 5 
patients didn’t have muscle spasm. Prevalence of muscle spasm was found to be highest 
in  complicated falciparum malaria. When the data were analyzed with fisher’s exact test 
,it was found to be statistically significant(p-value <0.01) 
 
Types of Malaria 
Muscle spasm 
Yes No Total 
N % N % N % 
Complicated falciparum 
9 60.0% 6 40.0% 15 
100.0
% 
Uncomplicated falciparum 
5 14.7% 29 85.3% 34 
100.0
% 
Complicated vivax 
4 40.0% 6 60.0% 10 
100.0
% 
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Uncomplicated vivax 
2 5.0% 38 95.0% 40 
100.0
% 
Complicated mixed 
1 16.7% 5 83.3% 6 
100.0
% 
Uncomplicated mixed 
1 20.0% 4 80.0% 5 
100.0
% 
Total 
22 20.0% 88 80.0% 110 
100.0
% 
 
 
*  p value <0.05 is significant 
Chi-Square Test Value p-value 
Fisher's Exact Test 21.498 <0.001* 
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No patients in the study population presented with  convulsions 
  Only 2 patients in the study population presented with numbness. Both of them were 
having complicated falciparum malaria. It was found to be statistically insignificant. 
Types of Malaria 
Numbness 
Yes No Total 
N % N % N % 
Complicated falciparum 
2 13.3% 13 86.7% 15 
100.0
% 
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Uncomplicated falciparum 
0 0.0% 34 
100.0
% 
34 
100.0
% 
Complicated vivax 
0 0.0% 10 
100.0
% 
10 
100.0
% 
Uncomplicated vivax 
0 0.0% 40 
100.0
% 
40 
100.0
% 
Complicated mixed 
0 0.0% 6 
100.0
% 
6 
100.0
% 
Uncomplicated mixed 
0 0.0% 5 
100.0
% 
5 
100.0
% 
Total 
2 1.8% 108 98.2% 110 
100.0
% 
 
Chi-Square Test Value p-value 
Fisher's Exact Test 8.102 0.080 
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                                  DISCUSSIONS 
(If P-Value is <0.05 then statistically significant) 
  The Normality tests Kolmogorov-Smirnov and Shapiro-Wilks tests results reveal that 
the variables follow Normal distribution. Therefore, to analyze the data Parametric 
methods are applied. To compare the mean values between different types of Malaria 
one-way ANOVA is applied followed by Tukey’s HSD post hoc tests for multiple pair 
wise comparisons. To compare two mean values independent samples t-test is applied.  
To compare proportions Chi-Square test is applied, if any expected cell frequency is less 
than five then Fisher’s exact test is used. To analyze the data SPSS (IBM SPSS Statistics 
for Windows, Version 23.0, Armonk, NY: IBM Corp. Released 2015) is used. 
Significance level is fixed as 5. 
   The data were analyzed statistically and results were compared with literature 
reviewed, as given below. 
Prevalence of hypocalcemia in malaria 
  In our study, hypocalcemia was found to be more prevalent in complicated malaria than 
uncomplicated malaria. This result concurs with most of the literature we reviewed. 
   Prabha et al in her study observed that 27 (45%) out of 60 malarial cases were having 
hypocalcemia. 88.24% of complicated malarial patients developed hypocalcemia while 
only 27.19% patients with uncomplicated malaria had hypocalcemia. So she concluded 
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that hypocalcemia is not uncommon in malaria and found to be more prevalent in 
complicated malarial cases. 
Dr Seema Mishra et all detected hypocalcemia in 44 (62.86%) out of 70 cases of 
malaria.She concluded that hypocalcemia is a feature of severe/complicated malaria as 
it had a good correlation with parasite load and complications. 
    Ankush agarwall et all in their study found that 155 (63%) out of 246 malarial patients 
studied developed hypocalcemia. 
   Sony C L et all conducted a study on prognostic implication of hypocalcemia and QTc 
interval in malaria. Out of 100 malarial cases studied 26(26%) were found to have 
hypocalcemia. 
    David TM et all in their study observed that 12(66.66%) out of 18 patients with 
malaria had hypocalcemia. 
   T M E Davis et all studied about calcium and phosphate metabolism in acute 
falciparum malaria. 61(35.47%) out of 172 adults with malaria developed hypocalcemia. 
He could not find out difference in degree of hypocalcemia between those with 
uncomplicated and complicated malaria.He concluded that mild hypocalcemia in malaria 
is common regardless of  disease severity. 
   Ayoola oo et all in their study detected hypocalcemia in 23% of malarial cases. 
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Mohapathra M K et all studied about parathyroid dysfunction in complicated falciparum 
malaria.The study revealed the occurrence of hypocalcemia,hypomagnesemia and 
hypophosphatemia in malaria, regardless of disease severity. 
     Mohsin Ali Baloch et all conducted  a study on determination of serum calcium in 
patients with malaria by flame photometer. They observed hypercalcemia in malarial 
cases. This finding deviates from our study results. 
    Zyed ahammed zaki et all in their review article stated that asymptomatic 
hypocalcemia is seen in 1/3rd  cases of malaria. 
  Maitland et all in their study observed that hypocalcemia was infrequent at any point of 
time in 52 kenyan children with severe malaria. It is against our findings.  
Prevalence of hypocalcemia in different types of malaria 
In our study, prevalence of hypocalcemia was found to be highest in those with 
complicated falciparum malaria (69.4%). It is also observed that complexity/severity of  
any type of malaria doesn’t seem to have any influence on serum calcium level. 
Ankush agarwall et all in their study found that 94(65.28%) out of 144 falciparum 
malarial cases were having hypocalcemia. 50% cases of vivax malaria (43 out of 86 
cases) had hypocalcemia. 18 out 28 patients with mixed malarial infection developed 
hypocalcemia. Hypocalcemia was found to be prevalent in falciparum and mixed malarial 
infection. 
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Sony C L et all in their study found out that hypocalcemia  was found significantly in 
complicated falciparum and mixed infection as compared to uncomplicated falciparum 
and vivax malarial infection.  
  Asima rani et all in their study noted that there is no significant difference in the  
prevalence of hypocalcemia in falciparum and vivax malaria. This finding is not 
consistent with our results. 
   David T M et all in their study observed that 7 out of 10 cases of falciparum malaria 
had hypocalcemia while 5 out of 8 vivax malarial case developed hypocalcemia. 
T M E Davis et all did a study on  calcium and phosphate metabolism in acute falciparum 
malaria. 61(35.47%) out of 172 adults with malaria developed hypocalcemia. He could 
not find out difference in degree of hypocalcemia between those with uncomplicated and 
complicated malaria.He concluded that mild hypocalcemia in malaria is common 
regardless of  disease severity.  It is consistent with our findings. 
Mohapathra M K et all studied about parathyroid dysfunction in complicated falciparum 
malaria.The study revealed the occurrence of hypocalcemia, hypomagnesemia and 
hypophosphatemia in malaria, regardless of  severity of falciparum  malaria. This finding 
is consistent with our study results. 
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Mean serum calcium level in different types of malaria 
Lowest mean serum calcium was observed in complicated falciparum malaria while 
highest mean serum calcium was observed in uncomplicated mixed malarial infection. 
That was7.429 mg% and 8.940 mg% respectively.  
   Prabha M R et all in their study found out that mean  serum calcium level in 
complicated malaria was (7.4 +/- 0.98mg%) against (8.4 /- 0.4mg%) in uncomplicated 
malaria. 
Dr Seema Mishra et all in their study observed that mean serum calcium level in 
complicated falciparum, complicated mixed ,uncomplicated falciparum and vivax 
malarial infection were (7.06 +/- 0.77 ) mg%, (7.02 +/- 0.49 ), (8.07 +/- 1.07) mg% and 
(8.68 +/- 03)mg% respectively. Complicated malarial cases were found to have 
significant hypocalcemia. 
Sony C L et all observed a mean serum calcium of  8.16 +/- 0.97 mg% , 8.72 +/- 0.97 
mg% , 9.77 +/- 1.34 mg%  and  9.68 +/- 0.99 mg% in complicated falciparum malaria, 
mixed infection, uncomplicated falciparum and vivax malaria respectively. He concluded 
that hypocalcemia  was found significantly in complicated falciparum and mixed 
infection as compared to uncomplicated falciparum and vivax malarial infection. 
   Asima rani et all in their study reported mean serum calcium level in P.falciparum, 
P.vivax infection and normal healthy individual were 6.52 +/- 1.09 mg% ,6.07 +/- 1.32 
mg% and 9.08 +/- 4.48 mg% respectively.  
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   J C Petithory et all in their study found out that those with malaria had an average 
calcium of 8.75 mg% whereas those without malaria had an average serum calcium of 
9.15mg%. 
Prevalence of QTc prolongation in malaria 
    In our study, it is found thatprevalence of QTc prolongation was higher in complicated 
malaria than that in uncomplicated malaria. Prevalence of QTc prolongation was highest 
in falciparum  malarial fever.80% of patients with complicated falciparum malaria 
patients had prolonged QTc. Prevalence of QTc prolongation in complicated vivax 
malaria and complicated mixed malarial infection were 60% and 33.3% respectively. 
Complicated falciparum malaria was found to have highest prevalence of QTc 
prolongation.The association between QTc prolongation and hypocalcemia was found to 
be statistically significant only  in complicated and uncomplicated vivax malaria. 
Prabha et all  noted significant correlation between degree of hypocalcemia and QTc 
prolongation. 
   Dr Seema Mishra et all noted that all 44 malarial patients with hypocalcemia had QTc 
prolongation. 
  Sony C L et all in their study found that all 26 cases of malaria with hypocalcemia had 
QTc prolongation. She concluded that QTc prolongation was significant in complicated 
falciparum and mixed malarial infection as compared to uncomplicated falciparum and 
vivax malaria. 
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Sudhindra Rao Mananje et all carried out  a study on QTc prolongation as an indicator of 
complications in malaria. 92 patients were included in the study. 12 patients had 
prolonged QTc. 10 out of 12 patients had associated complications. Of 80 patients with 
normal QTc ,only 17 patients developed complications.He concluded that, QTc 
prolongation is significantly associated with P.vivax malaria and AKI in malaria. 
Mean QTc in different types of malaria 
  Longest mean QTc was observed in complicated falciparum malarial fever while 
uncomplicated vivax malarial cases had shortest QTc. That was 0.4587 sec and 0.4385 
sec respectively. There was no significant difference in QTc interval between different 
types of malaria. 
Dr Seema Mishra et all found out that mean QTc interval in complicated falciparum, 
complicated mixed infection, uncomplicated falciparum and vivax malaria were (0411 
+/- 0.038) sec , (0.512 +/- 0.033) sec ,),(0.435 +/- 0.035) sec and ),(0.403 +/- 0.019)  sec 
respectively. Vivax malaria was found to have shortest mean QTc and complicated 
mixed infection had longest mean QTc. 
  Sony C L et all in their observed  that mean QTc interval in complicated falciparum, 
complicated mixed infection, uncomplicated falciparum and vivax malaria  were 0.468 
+/- 0.055 sec ,, 0.442 +/- 0.043 sec ,0435 +/- 0.035 sec and 0.403 +/- 0.019 sec 
respectively. Complicated falciparum malaria had longest QTc while vivax malaria had 
shortest QTc. 
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Prevalence of symptomatic hypocalcemia in malaria 
In our study, 22 (20%) out of 110 patients with malaria had muscle spasm. 80% malarial 
cases didn’t have muscle spasm. No patients had convulsions. Only 2 (1.8%) out of 110 
patients with malarial fever presented with numbness. Prevalence of muscle spasm was 
found to be highest in  complicated falciparum malaria. 
    There was not much studies conducted regarding prevalence of symptomatic 
hypocalcemia in malaria. 
   Dr Seema Mishra et all in their study observed that 5 out of 8 malarial case presented 
with muscle spasm  had hypocalcemia. She also noted that  10 out of 14 malarial cases 
presented with convulsion had hypocalcemia. 
Sony C L et all noted that 8 out of 10 patients presented with convulsion had 
hypocalcemia. Hypocalcemia was noted in 4 out of 8 patients with muscle spasm. 
Zayed ahammed zaki et all had reported a case of  falciparum malaria ,presented as 
tetany. 12 years old boy was admitted with complaints of fever, chills and rigor and 
painful intermittent muscle spasm of left foot. Serum calcium was 7.1 mg%.  Symptoms 
got relieved after hypocalcemia correction and artesunate therapy. 
Akinyele akinlade et all had reported a case of falciparum malaria presented with high 
grade fever, chills, vomiting, epigastric pain and cramps in hands and feet. She also had 
carpopedal spasm. Serum calcium was 1.37 mmol/l and QTc was prolonged. She was 
treated with iv calcium and artesunate. 
103 
 
                                        CONCLUSIONS 
1. Prevalence of hypocalcemia in malaria was found to be 55.5% in our study. 
2. Hypocalcemia was more prevalent in complicated malaria than uncomplicated 
malaria 
3. Among different types of malaria, prevalence of hypocalcemia was highest in 
falciparum malaria. 
4. Complicated falciparum malaria showed highest prevalence of hypocalcemia. 
Status of complexity  of malaria was not found to be related to occurrence of 
hypocalcemia in any types of malaria. 
5. Lowest mean serum calcium was observed in complicated falciparum malaria 
while highest mean serum calcium was seen in uncomplicated mixed malarial 
infection 
6. Prevalence of QTc prolongation in malaria was found to be 49.1%. 72.1% of 
patients with hypocalcemia had prolonged QTc. 
7. Prevalence of QTc prolongation was found to be more in complicated malaria than 
uncomplicated malaria. 90% of complicated malarial patients with QTc 
prolongation were found to have hypocalcemia. 
8. QTc prolongation was most prevalent in complicated falciparum malaria. 83.3% 
of those with QTc prolongation had hypocalcemia. 
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9. Longest QTc was observed in complicated falciparum malaria while shortest was 
in uncomplicated vivax malaria. There was no significant difference in QTc 
between different types of malaria. 
10. Prevalence of muscle spasm in malaria was found to be 20%. Muscle spasm was 
most prevalent in complicated falciparum malaria 
11. Prevalence of numbness in malaria was 1.8% 
12. There was no statistically significant difference of prevalence of hypocalcemia in 
malaria between males and females. 
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                                LIMITATIONS 
1. Limited number patients were evaluated 
2. It was a cross sectional study. Serum calcium and QTc at the time of 
admission was evaluated. Development of hypocalcemia or QTc 
prolongation during treatment was not considered. 
3. Other electrolyte abnormalities (eg : hypokalemia) that can cause QTc 
prolongation were not considered. 
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                            RECOMMENDATIONS 
1. Studies may be undertaken with more number of patients in all age groups 
2. A prospective studies may be undertaken to find out the exact incidence of 
hypocalcemia in malaria 
3. It will be interesting to analyze occurrence of hypokalemia  in malaria. Its 
association with QTc prolongation may be found out. 
4. Studies may be undertaken to find out  association between serum calcium 
level and serum PTH. 
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STUDY PROFOMA 
NAME :     AGE:     SEX: 
ADDRESS:     CONTACT NO: 
COMPLAINTS: 
HISTORY: 
 
 ALCOHOLISM             YES           NO   DURATION:  
 HEAD INJURY             YES             NO 
 HYPOTHYROIDISM    YES             NO 
 KIDNEY DISEASE          YES           NO 
 SMOKER                        YES           NO 
LIVER DISEASE               YES            NO 
THYROID  SURGERIES     YES          NO 
 H/O   MEDICATION 
RELEVANT CLINICAL EXAMINATION: 
111 
 
GENERAL EXAMINATION  
SYSTEMIC EXAMINATION: 
CARDIOVASCULAR: 
RESPIRATORY: 
ABDOMEN : 
CNS: 
MUSCULO SKELETAL SYSTEM: 
LABORATORY  INVESTIGATIONS 
HB:    TC:    PLATELET: 
RBS          RFT: 
LFT 
SERUM  CALCIUM: 
PERIPHERAL SMEAR: 
QBC: 
ECG  FINDINGS:                                                       
 COMMENT: 
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GOVT. STANLEY MEDICAL COLLEGE, CHENNAI –600001 
INFORMED CONSENT 
“PREVALENCE AND CLINICAL IMPLICATION OF HYPOCALCEMIA                                              
IN MALARIA” 
Place of study:  Govt. Stanley medical college, Chennai 
 
I ……………………………………………. have been informed about the details of the 
study in my own language. 
I have completely understood the details of the study. 
I am aware of the possible risks and benefits, while taking part in the study. 
I agree to collect samples of blood/saliva/urine/tissue if study needs. 
I understand that I can withdraw from the study at any point of time and even then, I can 
receive the medical treatment as usual. 
I understand that I will not get any money for taking part in the study. 
I will not object if the results of this study are getting published in any medical journal, 
provided my personal identity is not revealed. 
I know what I am supposed to do by taking part in this study and I assure that I would 
extend my full cooperation for this study. 
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Volunteer:       Witness: 
Name and address        Name and address 
Signature/thumb impression:   Signature/thumb impression 
Date:        Date: 
 
 
Investigator Signature and date 
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GOVT. STANLEY MEDICAL COLLEGE, CHENNAI – 600001 
INFORMED CONSENT 
“PREVALENCE AND CLINICAL IMPLICATION OF HYPOCALCEMIA IN 
MALARIA’’ 
AT GOVERNMENT STANLEY HOSPITAL, CHENNAI. 
 
நான்இந்தஆராய்ச்சியில்விவரங்களைமுற்றிலும்புாிந்துககாண்டேன். 
ஆய்வில்பங்குஎடுத்துடபாது, 
சாத்தியமானஅபாயங்கள்மற்றும்பயன்களைபற்றிநான்அறிந்துள்டைன். 
நான்எந்தகவாருடவளையிலும்ஆய்வில்இருந்துதிரும்பமுடியும், அதன்பின்னர், 
நான்வழக்கம்டபால்மருத்துவசிகிச்ளசகபறமுடியும்என்றுபுாிந்துககாள்கிடறன் 
நான்ஆய்வில்பங்குஎடுத்துபணம்எளதயும்கபறமுடியாதுஎன்றுஅறிந்துள்டைன். 
இந்தஆய்வின்முடிவுகள்எந்தகமடிக்கல்ஜர்னலில்கவைியிேப்பேஇருந்தால்நான்எதி
ர்க்கவில்ளை, என்தனிப்பட்ேஅளேயாைத்ளதகவைிப்படுத்தப்பட்டுஇருக்ககூோது. 
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நான்இந்தஆய்வில்பங்ககடுப்பதன்மூைம்நான்என்னகசய்யடபாகிடறன்என்றுகதாி
யும் 
நான்இந்தஆய்வில்என்முழுஒத்துளழப்ளபயும்ககாடுப்டபன்என்றுஉறுதியைிக்கிடற
ன். 
 
 
தன்னார்வைர்       சாட்சி 
கபயர்மற்றும்முகவாி     கபயர்மற்றும்முகவாி 
ளககயாப்பம் / விரல்டரளக:      ளககயாப்பம் / 
விரல்டரளக: 
 
ஆராய்ச்சியாைராக    ளககயாப்பம்மற்றும்டததி 
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FINANCIAL DISCLOSURE 
There was no financial interest while conducting the study. 
Sl.No NAME AGE SEX DIFFERENT TYPES OF MALARIA SERUM CALCIUM QTC MUSCLE SPASM CONVULSIONS NUMBNESS
1 SELVI 58 F 2 8.9 0.49 N N N
2 ANUSHIYA 15 F 5 6.9 0.49 N N N
3 DESAYAN 15 M 4 8.9 0.41 N N N
4 SELVI 13 F 2 9.1 0.42 N N N
5 SELLADURAI 68 M 1 7.2 0.45 Y N N
6 MANNARU 68 M 3 7.7 0.46 Y N N
7 DATCHANA MOORTHY 55 M 4 7.7 0.46 N N N
8 GEETHA 32 F 1 8.2 0.46 N N N
9 RAJESH KUMAR 24 M 2 7.8 0.49 N N N
10 ROSELIN JOSEPH 23 F 4 7.8 0.42 N N N
11 MEENA 67 F 2 8.1 0.43 N N N
12 DASS 18 M 1 7.6 0.43 N N N
13 THANVIR 18 M 2 8 0.47 N N N
14 RAMKUMAR 20 M 4 7.7 0.47 N N N
15 JOTHI 57 F 2 6.9 0.47 Y N N
16 NARESH 21 M 2 10 0.42 N N N
17 ARUNACHALAM 51 M 4 9.1 0.45 N N N
18 MALATHI 32 F 3 9 0.42 N N N
19 MUTHULAKSHMI 62 F 2 9.3 0.48 N N N
20 INDRANI 56 F 2 7.3 0.47 N N N
21 SABITH 18 M 2 6.6 0.41 Y N N
22 HASEEN 36 M 4 6.9 0.42 Y N N
23 THANGARAJ 55 M 1 6.9 0.48 Y N N
24 KALLIYAPERUMAL 70 M 4 10 0.42 N N N
25 ANBAZHAGAN 67 M 3 6.3 0.47 Y N N
26 BOOMINATHAN 60 M 2 7.9 0.42 N N N
27 SHANMUGAN 60 M 1 7.1 0.45 Y N N
28 RAJESWARI 33 F 2 10.1 0.41 N N N
29 SUSEELA 50 F 2 6.5 0.47 Y N N
30 CHANDRA 48 F 5 6.6 0.48 Y N N
31 NABISA 51 F 4 9.9 0.43 N N N
32 CHIMMAYAIN 66 M 2 7 0.43 N N N
33 KARTHIKEYAN 71 M 1 6.2 0.49 Y N N
34 ARUN 23 M 4 7.8 0.49 N N N
35 ASLAM 18 M 4 9.6 0.43 N N N
36 NATESAN 61 M 2 6.8 0.47 N N N
37 SURESH 21 M 2 6.5 0.45 N N N
38 MOHAN 28 M 6 9.1 0.43 N N N
CLINICAL FEATURES
39 NAGARAJ 23 M 1 6.6 0.47 Y N N
40 RAVI 39 M 1 8.9 0.46 N N N
41 LOGESWARI 13 F 6 9.5 0.42 N N N
42 SARAVANAN 25 M 4 7.3 0.49 N N N
43 ANJALI 55 F 2 7.1 0.47 N N N
44 RANGASAMY 56 M 2 9.6 0.43 N N N
45 BABU 42 M 4 9.7 0.42 N N N
46 SWETHA 16 F 1 7 0.46 N N Y
47 SUDHA 28 F 4 10 0.42 N N N
48 NAVEEN 19 M 4 7.9 0.49 N N N
49 ARUMUGASAMY 52 M 4 8.3 0.43 N N N
50 AMBUSELVAM 45 M 2 9.2 0.41 N N N
51 LAKSHMI 16 F 1 6.3 0.49 Y N N
52 SRINIVASAN 30 M 4 8.9 0.42 N N N
53 KAMMARUNNISA 55 F 6 9.7 0.45 N N N
54 DILEEP KUMAR 33 M 4 9.1 0.44 N N N
55 SUJITH VARMA 16 M 2 6.8 0.42 N N N
56 DINESH KUMAR 17 M 2 9.6 0.42 N N N
57 JACOB 29 M 4 9.1 0.41 N N N
58 JOSEPH 35 M 6 8.9 0.42 N N N
59 PERIYASAMY 42 M 4 8 0.42 N N N
60 GANGA 25 F 5 10 0.42 N N N
61 SAKTHIVEL 24 M 2 7.2 0.48 N N N
62 REVATHY 24 F 2 9.2 0.41 N N N
63 PRASADH 21 M 4 7.7 0.47 N N N
64 HARI LAL 51 M 4 9 0.42 N N N
65 PRIYA 35 F 5 7.5 0.42 N N N
66 ANJALI 18 F 4 7.5 0.43 N N N
67 KASTHURI 39 F 4 9.3 0.43 N N N
68 RAMESH 52 M 2 10 0.46 N N N
69 NAVAMANI 42 M 1 6.6 0.48 Y N N
70 RAMU 40 M 2 6.9 0.49 N N N
71 SUNDARI 32 F 4 9.3 0.43 N N N
72 MUHAMMED HAJI 64 M 4 8.2 0.48 N N N
73 CHANDRASEKHAR 54 M 5 7.3 0.43 N N N
74 HANIFA 54 M 2 6.6 0.45 Y N N
75 KALA 20 F 2 9.6 0.47 N N N
76 PETER 41 M 6 7.5 0.48 Y N N
77 RADHA 54 F 3 8.2 0.47 N N N
78 EZHUMALAI 54 M 4 9.3 0.45 N N N
79 RAMA DEVI 45 F 4 9 0.42 N N N
80 RADHAKRISHNAN 49 M 4 9 0.41 N N N
81 SURESH 33 M 1 9.1 0.45 N N N
82 RADHA 22 F 4 7.6 0.46 N N N
83 SANDHYA 15 F 4 10.1 0.42 N N N
84 SAMBATH 15 M 3 9.3 0.42 N N N
85 SASIKUMAR 38 M 4 9.9 0.42 N N N
86 GOKUL 26 M 2 7.7 0.48 N N N
87 RAMKUMAR 31 M 2 8.2 0.41 N N N
88 VIJAYALAKSHMI 35 F 4 9.7 0.42 N N N
89 ARUL SANTHA 68 F 3 6.9 0.48 Y N N
90 RAMESH 24 M 4 7.1 0.46 Y N N
91 SANTHA 38 F 4 10 0.43 N N N
92 MUTHUKUMAR 58 M 4 9.9 0.44 N N N
93 RAMESH 26 M 1 7.4 0.45 Y N N
94 MEENATCHI 55 F 4 8.4 0.48 N N N
95 GANESAN 50 M 3 9.2 0.42 N N N
96 MEENATCHI 35 F 4 9.2 0.42 N N N
97 KANDAN 69 M 3 8.7 0.47 N N N
98 GOWRI 69 F 4 9.7 0.43 N N N
99 RAMAN 70 M 5 9.1 0.42 N N N
100 SIVAGAMY 35 F 4 9 0.46 N N N
101 SRUTHI 28 F 2 7.8 0.45 N N N
102 SUNDARI 45 F 1 9.5 0.43 N N N
103 DURAISAMI 70 M 2 7.2 0.44 N N N
104 SHUHAIB 19 M 3 9.9 0.43 N N N
105 MALARMATHI 30 F 4 8.6 0.42 N N N
106 THULASI RAM 22 M 3 7.1 0.48 Y N N
107 VAISHNAVI 22 F 2 7.9 0.49 N N N
108 BALAMURUGAN 59 M 2 6.6 0.49 Y N N
109 PETER 47 M 1 6.8 0.43 Y N Y
110 MOHD.HANEEFA 66 M 2 10.2 0.43 N N N
complicated falciparum malaria 1
uncomplicated falciparum  malaria 2 normal serum calcium 8.8-10.5mg%
complicated vivax malaria 3 hypocalcemia <8.8mg%
uncomplicated vivax malaria 4 hypercalcemia >10.5mg%
complicated mixed infection 5
uncomplicated mixed infection 6
QTc prolongation >0.44seconds
